Aethlon Interest Coverage vs Ev To Sales Analysis

AEMD Stock

USD 0.58 0.15 34.88%

Aethlon Medical financial indicator trend analysis is way more than just evaluating Aethlon Medical prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Aethlon Medical is a good investment. Please check the relationship between Aethlon Medical Interest Coverage and its Ev To Sales accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aethlon Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

For information on how to trade Aethlon Stock refer to our How to Trade Aethlon Stock guide.

Interest Coverage vs Ev To Sales

Interest Coverage vs Ev To Sales Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Aethlon Medical Interest Coverage account and Ev To Sales. At this time, the significance of the direction appears to have strong relationship.

The correlation between Aethlon Medical's Interest Coverage and Ev To Sales is 0.68. Overlapping area represents the amount of variation of Interest Coverage that can explain the historical movement of Ev To Sales in the same time period over historical financial statements of Aethlon Medical, assuming nothing else is changed. The correlation between historical values of Aethlon Medical's Interest Coverage and Ev To Sales is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Interest Coverage of Aethlon Medical are associated (or correlated) with its Ev To Sales. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ev To Sales has no effect on the direction of Interest Coverage i.e., Aethlon Medical's Interest Coverage and Ev To Sales go up and down completely randomly.

Correlation Coefficient

0.68

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Interest Coverage

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.

Most indicators from Aethlon Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Aethlon Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aethlon Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

For information on how to trade Aethlon Stock refer to our How to Trade Aethlon Stock guide.At present, Aethlon Medical's Enterprise Value Over EBITDA is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value Multiple is expected to grow to 0.01, whereas Sales General And Administrative To Revenue is forecasted to decline to 6.30.

Aethlon Medical fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Property Plant And Equipment Net	Accounts Payable	Property Plant And Equipment Gross	Intangible Assets	Short Long Term Debt Total	Current Deferred Revenue	Other Assets	Net Receivables	Inventory	Other Current Assets
Total Assets		-0.27	-0.34	0.86	-0.97	-0.74	0.97	0.65	0.45	0.97	-0.4	0.68	0.79	-0.3	0.97	-0.38	0.68	-0.07	0.56	-0.77	-0.36	-0.4	-0.06	-0.32	-0.84	0.19
Other Current Liab	-0.27		0.94	-0.7	0.39	0.23	-0.27	-0.17	-0.17	-0.27	0.93	-0.22	-0.33	0.95	-0.26	0.92	-0.19	0.33	-0.18	0.45	0.68	0.85	-0.03	0.19	0.29	-0.1
Total Current Liabilities	-0.34	0.94		-0.77	0.49	0.27	-0.35	-0.16	-0.15	-0.35	0.98	-0.21	-0.37	1.0	-0.34	0.97	-0.19	0.48	-0.17	0.53	0.86	0.96	0.07	0.36	0.32	-0.14
Total Stockholder Equity	0.86	-0.7	-0.77		-0.92	-0.65	0.85	0.52	0.39	0.85	-0.8	0.58	0.74	-0.74	0.84	-0.78	0.56	-0.3	0.47	-0.81	-0.71	-0.79	-0.07	-0.4	-0.76	0.21
Net Debt	-0.97	0.39	0.49	-0.92		0.67	-0.98	-0.5	-0.31	-0.98	0.52	-0.55	-0.73	0.46	-0.97	0.5	-0.54	0.25	-0.41	0.74	0.55	0.55	0.06	0.34	0.8	-0.26
Retained Earnings	-0.74	0.23	0.27	-0.65	0.67		-0.64	-0.74	-0.7	-0.64	0.34	-0.78	-0.99	0.22	-0.64	0.36	-0.73	-0.04	-0.72	0.65	0.32	0.41	0.62	0.43	0.8	-0.1
Cash	0.97	-0.27	-0.35	0.85	-0.98	-0.64		0.47	0.24	1.0	-0.38	0.51	0.69	-0.33	1.0	-0.35	0.52	-0.18	0.37	-0.66	-0.39	-0.4	-0.01	-0.24	-0.77	0.24
Non Current Assets Total	0.65	-0.17	-0.16	0.52	-0.5	-0.74	0.47		0.9	0.47	-0.26	0.96	0.76	-0.1	0.47	-0.27	1.0	0.4	0.99	-0.82	-0.1	-0.25	-0.13	-0.52	-0.72	-0.1
Non Currrent Assets Other	0.45	-0.17	-0.15	0.39	-0.31	-0.7	0.24	0.9		0.24	-0.25	0.93	0.72	-0.09	0.25	-0.29	0.87	0.45	0.95	-0.75	-0.13	-0.25	-0.27	-0.5	-0.63	-0.15
Cash And Short Term Investments	0.97	-0.27	-0.35	0.85	-0.98	-0.64	1.0	0.47	0.24		-0.38	0.51	0.69	-0.33	1.0	-0.35	0.52	-0.18	0.37	-0.66	-0.39	-0.4	-0.01	-0.24	-0.77	0.24
Common Stock Total Equity	-0.4	0.93	0.98	-0.8	0.52	0.34	-0.38	-0.26	-0.25	-0.38		-0.32	-0.45	0.97	-0.38	1.0	-0.28	0.47	-0.27	0.59	0.82	0.97	0.09	0.34	0.41	-0.14
Common Stock Shares Outstanding	0.68	-0.22	-0.21	0.58	-0.55	-0.78	0.51	0.96	0.93	0.51	-0.32		0.81	-0.16	0.51	-0.34	0.95	0.38	0.96	-0.85	-0.2	-0.31	-0.15	-0.5	-0.82	-0.1
Other Stockholder Equity	0.79	-0.33	-0.37	0.74	-0.73	-0.99	0.69	0.76	0.72	0.69	-0.45	0.81		-0.32	0.68	-0.46	0.75	-0.01	0.74	-0.73	-0.4	-0.5	-0.56	-0.46	-0.83	0.12
Total Liab	-0.3	0.95	1.0	-0.74	0.46	0.22	-0.33	-0.1	-0.09	-0.33	0.97	-0.16	-0.32		-0.31	0.96	-0.13	0.49	-0.11	0.48	0.85	0.95	0.04	0.31	0.3	-0.16
Total Current Assets	0.97	-0.26	-0.34	0.84	-0.97	-0.64	1.0	0.47	0.25	1.0	-0.38	0.51	0.68	-0.31		-0.34	0.52	-0.17	0.37	-0.65	-0.37	-0.38	-0.01	-0.22	-0.77	0.23
Common Stock	-0.38	0.92	0.97	-0.78	0.5	0.36	-0.35	-0.27	-0.29	-0.35	1.0	-0.34	-0.46	0.96	-0.34		-0.29	0.44	-0.29	0.6	0.82	0.97	0.12	0.35	0.41	-0.13
Property Plant And Equipment Net	0.68	-0.19	-0.19	0.56	-0.54	-0.73	0.52	1.0	0.87	0.52	-0.28	0.95	0.75	-0.13	0.52	-0.29		0.37	0.97	-0.84	-0.13	-0.27	-0.08	-0.53	-0.73	-0.08
Accounts Payable	-0.07	0.33	0.48	-0.3	0.25	-0.04	-0.18	0.4	0.45	-0.18	0.47	0.38	-0.01	0.49	-0.17	0.44	0.37		0.42	-0.06	0.5	0.54	0.23	0.1	-0.05	-0.21
Property Plant And Equipment Gross	0.56	-0.18	-0.17	0.47	-0.41	-0.72	0.37	0.99	0.95	0.37	-0.27	0.96	0.74	-0.11	0.37	-0.29	0.97	0.42		-0.81	-0.12	-0.26	-0.17	-0.54	-0.68	-0.1
Intangible Assets	-0.77	0.45	0.53	-0.81	0.74	0.65	-0.66	-0.82	-0.75	-0.66	0.59	-0.85	-0.73	0.48	-0.65	0.6	-0.84	-0.06	-0.81		0.52	0.61	-0.01	0.68	0.82	-0.04
Short Long Term Debt Total	-0.36	0.68	0.86	-0.71	0.55	0.32	-0.39	-0.1	-0.13	-0.39	0.82	-0.2	-0.4	0.85	-0.37	0.82	-0.13	0.5	-0.12	0.52		0.9	0.24	0.47	0.39	-0.27
Current Deferred Revenue	-0.4	0.85	0.96	-0.79	0.55	0.41	-0.4	-0.25	-0.25	-0.4	0.97	-0.31	-0.5	0.95	-0.38	0.97	-0.27	0.54	-0.26	0.61	0.9		0.23	0.48	0.42	-0.15
Other Assets	-0.06	-0.03	0.07	-0.07	0.06	0.62	-0.01	-0.13	-0.27	-0.01	0.09	-0.15	-0.56	0.04	-0.01	0.12	-0.08	0.23	-0.17	-0.01	0.24	0.23		0.2	0.15	-0.18
Net Receivables	-0.32	0.19	0.36	-0.4	0.34	0.43	-0.24	-0.52	-0.5	-0.24	0.34	-0.5	-0.46	0.31	-0.22	0.35	-0.53	0.1	-0.54	0.68	0.47	0.48	0.2		0.44	0.22
Inventory	-0.84	0.29	0.32	-0.76	0.8	0.8	-0.77	-0.72	-0.63	-0.77	0.41	-0.82	-0.83	0.3	-0.77	0.41	-0.73	-0.05	-0.68	0.82	0.39	0.42	0.15	0.44		-0.17
Other Current Assets	0.19	-0.1	-0.14	0.21	-0.26	-0.1	0.24	-0.1	-0.15	0.24	-0.14	-0.1	0.12	-0.16	0.23	-0.13	-0.08	-0.21	-0.1	-0.04	-0.27	-0.15	-0.18	0.22	-0.17

Click cells to compare fundamentals

Aethlon Medical Account Relationship Matchups

Aethlon Medical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	10.4M	10.7M	19.4M	17.5M	8.2M	8.7M
Other Current Liab	584.1K	880.2K	852.6K	802.8K	761.5K	723.4K
Total Current Liabilities	1.1M	1.4M	1.8M	1.5M	1.8M	2.8M
Total Stockholder Equity	9.4M	9.4M	17.1M	15.1M	5.8M	6.1M
Net Debt	(9.5M)	(9.8M)	(16.3M)	(13.3M)	(4.5M)	(4.3M)
Retained Earnings	(112.0M)	(119.9M)	(130.3M)	(142.4M)	(154.6M)	(146.8M)
Cash	9.6M	9.9M	17.1M	14.5M	5.4M	3.0M
Non Current Assets Total	346.6K	317.2K	1.3M	2.4M	2.3M	2.4M
Cash And Short Term Investments	9.6M	9.9M	17.1M	14.5M	5.4M	3.0M
Common Stock Total Equity	17.7K	19.0K	9.4K	12.2K	14.0K	13.3K
Common Stock Shares Outstanding	341.5K	1.2M	1.5M	2.1M	2.5M	2.6M
Liabilities And Stockholders Equity	10.4M	10.7M	19.4M	17.5M	8.2M	8.7M
Other Stockholder Equity	121.4M	129.3M	147.4M	157.4M	160.3M	168.4M
Total Liab	1.1M	1.4M	2.4M	2.4M	2.5M	4.1M
Total Current Assets	10.0M	10.4M	18.2M	15.1M	5.9M	3.2M
Common Stock	9.4K	12.2K	15.4K	23.0K	2.6K	2.5K
Property Plant And Equipment Net	276.9K	201.3K	1.1M	2.3M	1.9M	2.0M
Accounts Payable	285.0K	337.7K	500.0K	432.9K	777.9K	566.0K
Property Plant And Equipment Gross	276.9K	201.3K	1.1M	2.3M	2.9M	3.0M
Intangible Assets	57.5K	57.0K	2.2K	1.7K	1.1K	1.0K
Short Long Term Debt Total	141.1K	42.5K	729.4K	1.2M	940.3K	949.8K
Other Current Assets	229.6M	341.1K	1.9M	557.6K	506.0K	480.7K
Accumulated Other Comprehensive Income	(368.3K)	(385.5K)	0.0	(6.1M)	(6.9K)	(7.3K)
Short Term Debt	98.6K	42.5K	126.9K	269.4K	290.6K	276.0K
Property Plant Equipment	140.5K	201.3K	1.1M	2.3M	2.6M	2.8M
Non Current Liabilities Total	42.5K	495.1K	602.5K	939.6K	649.8K	544.9K
Net Tangible Assets	9.4M	9.4M	17.1M	15.1M	17.3M	18.2M
Noncontrolling Interest In Consolidated Entity	(101.2K)	(126.0K)	(132.1K)	(136.9K)	(123.2K)	(117.1K)
Retained Earnings Total Equity	(99.5M)	(105.7M)	(112.0M)	(119.9M)	(107.9M)	(113.3M)
Capital Surpluse	105.6M	108.1M	121.4M	129.3M	148.7M	97.7M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

When determining whether Aethlon Medical is a strong investment it is important to analyze Aethlon Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Aethlon Medical's future performance. For an informed investment choice regarding Aethlon Stock, refer to the following important reports:

How To Invest In Aethlon

Details

Is Aethlon Stock a good investment?

Details

What is Aethlon Medical's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aethlon Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

For information on how to trade Aethlon Stock refer to our How to Trade Aethlon Stock guide.

You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aethlon Medical. If investors know Aethlon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aethlon Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(2.79)

Revenue Per Share

0.236

Quarterly Revenue Growth

42.782

Return On Assets

(0.50)

Return On Equity

(1.05)

The market value of Aethlon Medical is measured differently than its book value, which is the value of Aethlon that is recorded on the company's balance sheet. Investors also form their own opinion of Aethlon Medical's value that differs from its market value or its book value, called intrinsic value, which is Aethlon Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aethlon Medical's market value can be influenced by many factors that don't directly affect Aethlon Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Aethlon Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aethlon Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aethlon Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Aethlon Interest Coverage vs Ev To Sales Analysis

Interest Coverage vs Ev To Sales

Interest Coverage vs Ev To Sales Correlation Analysis

Correlation Coefficient

Interest Coverage

Ev To Sales

Aethlon Medical fundamental ratios Correlations

Aethlon Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Aethlon Medical fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Liab	+ 1.0	Total Current Liabilities
Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash
Property Plant And Equipment Net	+ 1.0	Non Current Assets Total
Total Current Assets	+ 1.0	Cash And Short Term Investments
Common Stock	+ 1.0	Common Stock Total Equity

Other Stockholder Equity	- 0.99	Retained Earnings
Cash And Short Term Investments	- 0.98	Net Debt
Cash	- 0.98	Net Debt
Total Current Assets	- 0.97	Net Debt
Net Debt	- 0.97	Total Assets
Net Debt	- 0.92	Total Stockholder Equity